+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Retinal Biologics Market Report 2025 - Product Thumbnail Image

Retinal Biologics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antivirals Market Report 2025 - Product Thumbnail Image

Antivirals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Interferons Market Report 2025 - Product Thumbnail Image

Interferons Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Interleukin Inhibitors Market Report 2025 - Product Thumbnail Image

Interleukin Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
Plasminogen Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Plasminogen Activators - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive landscape, 2025

  • Report
  • April 2025
  • 400 Pages
  • Global
From
Loading Indicator